A phase II, open-label, multicenter study of lapatinib (GW572016) in patients with metastatic breast cancer that has progressed on trastuzumab-containing reimens
Publication
, Conference
Blackwell, K; Kaplan, EH; Franco, SX; Marcom, PK; Maleski, J; Sorensen, M; Berger, MS
Published in: ANNALS OF ONCOLOGY
January 1, 2004
Duke Scholars
Published In
ANNALS OF ONCOLOGY
ISSN
0923-7534
Publication Date
January 1, 2004
Volume
15
Start / End Page
27 / 27
Publisher
OXFORD UNIV PRESS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Blackwell, K., Kaplan, E. H., Franco, S. X., Marcom, P. K., Maleski, J., Sorensen, M., & Berger, M. S. (2004). A phase II, open-label, multicenter study of lapatinib (GW572016) in patients with metastatic breast cancer that has progressed on trastuzumab-containing reimens. In ANNALS OF ONCOLOGY (Vol. 15, pp. 27–27). OXFORD UNIV PRESS.
Blackwell, Kimberly, Edward H. Kaplan, Sandra X. Franco, P Kelly Marcom, Janet Maleski, Mel Sorensen, and Mark S. Berger. “A phase II, open-label, multicenter study of lapatinib (GW572016) in patients with metastatic breast cancer that has progressed on trastuzumab-containing reimens.” In ANNALS OF ONCOLOGY, 15:27–27. OXFORD UNIV PRESS, 2004.
Blackwell K, Kaplan EH, Franco SX, Marcom PK, Maleski J, Sorensen M, et al. A phase II, open-label, multicenter study of lapatinib (GW572016) in patients with metastatic breast cancer that has progressed on trastuzumab-containing reimens. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2004. p. 27–27.
Blackwell, Kimberly, et al. “A phase II, open-label, multicenter study of lapatinib (GW572016) in patients with metastatic breast cancer that has progressed on trastuzumab-containing reimens.” ANNALS OF ONCOLOGY, vol. 15, OXFORD UNIV PRESS, 2004, pp. 27–27.
Blackwell K, Kaplan EH, Franco SX, Marcom PK, Maleski J, Sorensen M, Berger MS. A phase II, open-label, multicenter study of lapatinib (GW572016) in patients with metastatic breast cancer that has progressed on trastuzumab-containing reimens. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2004. p. 27–27.
Published In
ANNALS OF ONCOLOGY
ISSN
0923-7534
Publication Date
January 1, 2004
Volume
15
Start / End Page
27 / 27
Publisher
OXFORD UNIV PRESS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis